Metal Drugs and the Anticancer Immune Response
Open accessThe DOI matches its Crossref record; 1,300 of the 1,300 references it cites were found in a registry or an index.
Abstract
The immune system deploys a multitude of innate and adaptive mechanisms not only to ward off pathogens but also to prevent malignant transformation ("immune surveillance"). Hence, a clinically apparent tumor already reflects selection for those malignant cell clones capable of evading immune recognition ("immune evasion"). Metal drugs, besides their well-investigated cytotoxic anticancer effects, massively interact with the cancer-immune interface and can reverse important aspects of immune evasion. This topic has recently gained intense attention based on combination approaches with anticancer immunotherapy (e.g., immune checkpoint inhibitors), a strategy recently delivering first exciting results in clinical settings. This review summarizes the promising but still extremely fragmentary knowledge on the interplay of metal drugs with the fidelity of anticancer immune responses but also their role in adverse effects. It highlights that, at least in some cases, metal drugs can induce long-lasting anticancer immune responses. Important steps in this process comprise altered visibility and susceptibility of cancer cells toward innate and adaptive immunity, as well as direct impacts on immune cell populations and the tumor microenvironment. On the basis of the gathered information, we suggest initiating joint multidisciplinary programs to implement comprehensive immune analyses into strategies to develop novel and smart anticancer metal compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Items 801–1,000 of 1,300
Grenader, T., Nash, S., Plotkin, Y., Furuse, J., Mizuno, N., Okusaka, T., Wasan, H. S., Valle, J. W., & Bridgewater, J. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv253 · Cited by 70
Kleinerman, E. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92540-4 · Cited by 69
Conte, E., Camerino, G. M., Mele, A., De Bellis, M., Pierno, S., Rana, F., Fonzino, A., Caloiero, R., Rizzi, L., Bresciani, E., et al. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12185 · Cited by 69
Porta, C., Sica, A., & Riboldi, E. (2018) · The FEBS Journal · doi:10.1111/febs.14288 · Cited by 69
Tumor-infiltrating B cells: The ignored players in tumor immunology
Linnebacher, M., & Maletzki, C. (2012) · OncoImmunology · doi:10.4161/onci.20641 · Cited by 68
Han, S., Kim, K., Kim, H., Kwon, J., Lee, Y., Lee, C.-K., Song, Y., Lee, S.-J., Ha, N., & Kim, K. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-008-1122-9 · Cited by 68
Issan, Y., Kornowski, R., Aravot, D., Shainberg, A., Laniado-Schwartzman, M., Sodhi, K., Abraham, N. G., & Hochhauser, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092246 · Cited by 68
Tanaka, F., Yamaguchi, H., Ohta, M., Mashino, K., Sonoda, H., Sadanaga, N., Inoue, H., & Mori, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10597 · Cited by 68
Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity
Chiorazzi, A., Semperboni, S., & Marmiroli, P. (2015) · Toxics · doi:10.3390/toxics3030304 · Cited by 68
Takeyama, K., Seto, M., Uike, N., Hamajima, N., Ino, T., Mikuni, C., Kobayashi, T., Maruta, A., Muto, Y., Maseki, N., et al. (2000) · PubMed · Cited by 67
A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy
Zhao, C., Chen, X., Zang, D., Lan, X., Liao, S., Yang, C., Zhang, P., Wu, J., Li, X., Liu, N., et al. (2016) · Oncogene · doi:10.1038/onc.2016.114 · Cited by 67
Excellent response to chemotherapy post immunotherapy
Dwary, A. D., Master, S. R., Patel, A., Cole, C., Mansour, R. P., Mills, G. M., Koshy, N. V., Peddi, P., Burton, G. V., Hammoud, D. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20030 · Cited by 67
Deaglio, S., Canella, D., Baj, G., Arnulfo, A., Waxman, S., & Malavasi, F. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00105-3 · Cited by 66
Goebel, C., Kubicka-Muranyi, M., Tonn, T., González, J., & Gleichmann, E. (1995) · Archives of Toxicology · doi:10.1007/s002040050198 · Cited by 66
Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association
Alculumbre, S., Raieli, S., Hoffmann, C., Chelbi, R., Danlos, F.-X., & Soumelis, V. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.02.014 · Cited by 66
Thomas‐Schoemann, A., Batteux, F., Mongaret, C., Nicco, C., Chéreau, C., Annereau, M., Dauphin, A., Goldwasser, F., Weill, B. J., Lemare, F., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103094 · Cited by 66
Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity.
Maeda, K., Hazama, S., Tokuno, K., Kan, S., Maeda, Y., Watanabe, Y., Kamei, R., Shindo, Y., Maeda, N., Yoshimura, K., et al. (2011) · PubMed · Cited by 66
Arsenic ecotoxicology and innate immunity
Lage, C. R., Nayak, A., & Kim, C. H. (2006) · Integrative and Comparative Biology · doi:10.1093/icb/icl048 · Cited by 66
Okita, R., Yukawa, T., Nojima, Y., Maeda, A., Saisho, S., Shimizu, K., & Nakata, M. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1814-9 · Cited by 66
Tsave, O., Petanidis, S., Kioseoglou, E., Yavropoulou, M. P., Yovos, J. G., Anestakis, D., Androniki, T., & Salifoglou, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4013639 · Cited by 66
Guo, B., Li, L., Guo, J., Liu, A., Wu, J., Wang, H., Shi, J., Pang, D., & Cao, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17973 · Cited by 66
CIK as therapeutic agents against tumors
Introna, M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.008 · Cited by 66
Arsenic trioxide (As2O3) induces apoptosis through activation of Bax in hematopoietic cells
Zheng, Y., Yamaguchi, H., Tian, C., Lee, M. W., Tang, H., Wang, H., & Chen, Q. (2005) · Oncogene · doi:10.1038/sj.onc.1208484 · Cited by 65
Li, X.-S., Ke, M.-R., Zhang, M.-F., Tang, Q.-Q., Zheng, B.-Y., & Huang, J.-D. (2015) · Chemical Communications · doi:10.1039/c4cc09934f · Cited by 65
Samet, A., Śledzińska, A., Krawczyk, B., Hellmann, A. R., Nowicki, S., Kur, J., & Nowicki, B. J. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1886-9 · Cited by 65
ATR mediates cisplatin resistance in a p53 genotype-specific manner
Sangster-Guity, N., Conrad, B. H., Papadopoulos, N., & Bunz, F. (2011) · Oncogene · doi:10.1038/onc.2010.624 · Cited by 65
Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
Dolcetti, R., Re, V. D., & Canzonieri, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061602 · Cited by 65
Wasenius, V.-M., Jekunen, A. P., Monni, O. M., Joensuu, H., Aebi, S., Howell, S. B., & Knuutila, S. (1997) · Genes Chromosomes and Cancer · Cited by 65
Lesterhuis, W. J., de Vries, I. J. M., Aarntzen, E. A., de Boer, A., Scharenborg, N. M., van de Rakt, M., van Spronsen, D.-J., Preijers, F. W., Figdor, C. G., Adema, G. J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605935 · Cited by 64
Talbot, S., Nelson, R., & Self, W. T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.161 · Cited by 64
Ironing Out the Wrinkles in Host Defense: Interactions between Iron Homeostasis and Innate Immunity
Wang, L., & Cherayil, B. J. (2009) · Journal of Innate Immunity · doi:10.1159/000210016 · Cited by 64
Ferrocifen derivatives that induce senescence in cancer cells: selected examples
Bruyère, C., Mathieu, V., Vessières, A., Pigeon, P., Top, S., Jaouen, G., & Robert Kiss, A. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.08.015 · Cited by 64
Kraneveld, A. D., Rijnierse, A., Nijkamp, F. P., & Garssen, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.095 · Cited by 64
Yamasaki, S., Hasegawa, A., Hojyo, S., Ohashi, W., Fukada, T., Nishida, K., & Hirano, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039654 · Cited by 64
Tang, J., Chen, Z., Sun, B., Dong, J., Liu, J., Zhou, H., Wang, L., Bai, R., Miao, Q., Zhao, Y., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.11.021 · Cited by 64
Huang, X., Cui, S., & Shu, Y. (2015) · Immunologic Research · doi:10.1007/s12026-015-8734-1 · Cited by 64
Hofheinz, R., Dittrich, C., Jakupec, M. A., Drescher, A., Jaehde, U., Gneist, M., von Keyserlingk, N. G., Keppler, B. K., & Hochhaus, A. (2005) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp43590 · Cited by 64
Self-citationLi, Z., Yan, H., Chang, G., Hong, M., Dou, J., & Niu, M. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.09.005 · Cited by 64
Particle platforms for cancer immunotherapy
Serda, R. E. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s31756 · Cited by 63
Tsuchikawa, T., Miyamoto, M., Yamamura, Y., Shichinohe, T., Hirano, S., & Kondo, S. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1906-x · Cited by 63
Positive and negative functions of B lymphocytes in tumors
Shen, M., Sun, Q., Wang, J., Pan, W., & Ren, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10094 · Cited by 63
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
Nazarov, A. A., Baquié, M., Nowak-Sliwinska, P. M., Zava, O., van Beijnum, J. R., Groessl, M., Chisholm, D. M., Ahmadi, Z., McIndoe, J. S., Griffioen, A. W., et al. (2013) · Scientific Reports · doi:10.1038/srep01485 · Cited by 63
Gadducci, A., & Guerrieri, M. E. (2017) · Anticancer Research · doi:10.21873/anticanres.12042 · Cited by 63
Soliman, A. F., Anees, L. M., & Ibrahim, D. M. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1506-4 · Cited by 63
Intolerability of cobalt salt as erythropoietic agent
Ebert, B., & Jelkmann, W. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1528 · Cited by 62
Kovjazin, R., Eldar, T., Patya, M., Vanichkin, A., Lander, H. M., & Novogrodsky, A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0558fje · Cited by 62
Up-regulation of adenosine receptors in the cochlea by cisplatin
Ford, M. S., Nie, Z., Whitworth, C. A., Rybak, L. P., & Ramkumar, V. (1997) · Hearing Research · doi:10.1016/s0378-5955(97)00103-2 · Cited by 62
Lai, H., Zhao, Z., Li, L., Zheng, W., & Chen, T. (2015) · Metallomics · doi:10.1039/c4mt00312h · Cited by 62
Alte, B., Mohr, T. T., Pirker, C., Kryeziu, K., Kuhn, P., Buck, A., Hofmann, T., Gerner, C., Hermann, G., Koellensperger, G., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.009 · Cited by 62
Self-citationMerritt, R. E., Mahtabifard, A., Yamada, R. E., Crystal, R. G., & Korst, R. J. (2003) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00707-4 · Cited by 62
Nanomaterial Induced Immune Responses and Cytotoxicity
Ali, A. A., Suhail, M., Mathew, S., Shah, M. A., Harakeh, S., Ahmad, S., Kazmi, Z., Alhamdan, M. A. R., Chaudhary, A., Damanhouri, G., et al. (2015) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2016.10885 · Cited by 62
El‐Shitany, N. A., & Eid, B. G. (2017) · Environmental Toxicology · doi:10.1002/tox.22418 · Cited by 62
Platinum Chemotherapy Hypersensitivity
Otani, I. M., Wong, J. T., & Banerji, A. (2017) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2017.06.003 · Cited by 62
Treatments for Astrocytic Tumors in Children: Current and Emerging Strategies
Burzynski, S. R. (2006) · Pediatric Drugs · doi:10.2165/00148581-200608030-00003 · Cited by 61
Hu, J., Kinn, J., Zirakzadeh, A. A., Sherif, A., Norstedt, G., Wikström, A.-C., & Winqvist, O. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12060 · Cited by 61
Crowe, A. P., Jackaman, C., Beddoes, K. M., Ricciardo, B., & Nelson, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073684 · Cited by 61
Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
Groza, D., Gehrig, S., Kudela, P., Holcmann, M., Pirker, C., Dinhof, C., Schueffl, H. H., Sramko, M., Hoebart, J., Alioglu, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1424676 · Cited by 61
Self-citationInteractions of gold coordination complexes with DNA
Mirabelli, C. K., Sung, C.-M., Zimmerman, J. P., Hill, D. T., Mong, S., & Crooke, S. T. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90106-1 · Cited by 61
Jaspers, I., Samet, J. M., ERZURUM, S. C., & REED, W. A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.1.3989 · Cited by 61
Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice
Park, H. J., Stokes, J. A., Corr, M., & Yaksh, T. L. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2304-9 · Cited by 61
CD95-mediated cell signaling in cancer: mutations and post-translational modulations
Tauzin, S., Debure, L., Moreau, J., & Legembre, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0866-4 · Cited by 61
Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse
Gagliardi, R., Sava, G., Pacor, S., Mestroni, G., & Alessio, E. (1994) · Clinical & Experimental Metastasis · doi:10.1007/bf01753975 · Cited by 61
Mariya, T., Hirohashi, Y., Torigoe, T., Asano, T., Kuroda, T., Yasuda, K., Mizuuchi, M., Sonoda, T., Saito, T., & Sato, N. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0101 · Cited by 61
Balmert, S. C., Donahue, C., Vu, J. R., Erdös, G., Falo, L. D., & Little, S. R. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.006 · Cited by 61
McCoy, M. J., Lake, R. A., van der Most, R. G., Dick, I. M., & Nowak, A. K. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.362 · Cited by 60
Frost, P., Ng, C. P., Belldegrun, A. S., & Bonavida, B. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1169 · Cited by 60
Vareki, S. M., Rytelewski, M., Figueredo, R., Chen, D., Ferguson, P. J., Vincent, M. D., Min, W., Zheng, X., & Koropatnick, J. D. (2014) · Oncotarget · doi:10.18632/oncotarget.1916 · Cited by 60
Why does allergic contact dermatitis exist?
McFadden, J. P., Puangpet, P., Basketter, D. A., Dearman, R. J., & Kimber, I. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12145 · Cited by 60
Li, L., Li, W., Wang, C., Xu, Y., Wang, Y., Niu, C. S., Zhang, X., Li, M., Tian, H., Cheng, Y., et al. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.09.009 · Cited by 60
Ramachandran, E., Gandin, V., Bertani, R., Sgarbossa, P., Natarajan, K., Bhuvanesh, N. S. P., Venzo, A., Zoleo, A., Glisenti, A., Dolmella, A., et al. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.01.016 · Cited by 60
Recent Advances in Copper Intercalators as Anticancer Agents
Devi, C. S., Thulasiram, B., Aerva, R. R., & Nagababu, P. (2018) · Journal of Fluorescence · doi:10.1007/s10895-018-2283-7 · Cited by 60
Ruiz-Sánchez, P., König, C., Ferrari, S. M., & Alberto, R. A. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0697-z · Cited by 59
Mansfield, A. S., Fields, A. P., Jatoi, A., Qi, Y., Adjei, A. A., Erlichman, C., & Molina, J. R. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000009 · Cited by 59
Protection against cisplatin ototoxicity by adenosine agonists
Whitworth, C. A., Ramkumar, V., Jones, B., Tsukasaki, N., & Rybak, L. P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.01.010 · Cited by 59
Kim, Y. H., Choi, B. K., Kim, K. H., Kang, S. W., & Kwon, B. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1365 · Cited by 59
The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies
Lee, K., Briehl, M. M., Mazar, A. P., Batinic̈‐Haberle, I., Reboucas, J. S., Glinsmann‐Gibson, B., Rimsza, L. M., & Tome, M. E. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.003 · Cited by 59
Parker, J. P., Ude, Ž., & Marmion, C. J. (2015) · Metallomics · doi:10.1039/c5mt00181a · Cited by 59
Aude‐Garcia, C., Dalzon, B., Ravanat, J., Collin‐Faure, V., Diemer, H., Strub, J., Cianférani, S., DORSSELAER, A. V., Carrière, M., & Rabilloud, T. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.12.013 · Cited by 59
Heery, C. R., Madan, R. A., Stein, M. N., Stadler, W. M., DiPaola, R. S., Rauckhorst, M., Steinberg, S. M., Marté, J. L., Chen, C. C., Grenga, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10883 · Cited by 59
Gonçalves-Ribeiro, S., Díaz-Maroto, N. G., Berdiel-Acer, M., Soriano, A., Guardiola, J., Martínez-Villacampa, M., Salazar, R., Capellà, G., Villanueva, A., Martínez-Balibrea, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11121 · Cited by 59
Iron-sulfur clusters in mitochondrial metabolism: Multifaceted roles of a simple cofactor
Stiban, J., So, M., & Kaguni, L. S. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916100059 · Cited by 59
Arsenic trioxide synergizes with B7H3‐mediated immunotherapy to eradicate hepatocellular carcinomas
Luo, L., Qiao, H., Meng, F., Dong, X., Zhou, B., Jiang, H., Kanwar, J. R., Krissansen, G. W., & Sun, X. (2005) · International Journal of Cancer · doi:10.1002/ijc.21557 · Cited by 58
Update on immune checkpoint inhibitors in gynecological cancers
Heong, V., Ngoi, N., & Tan, D. S. P. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2017.28.e20 · Cited by 58
Ishizawa, S., Slovak, M. L., Popplewell, L. L., Bedell, V., Wrede, J. E., Carter, N. H., Snyder, D., & Arber, D. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402918 · Cited by 58
HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
Rutten, M. J., Dijk, F., Savci-Heijink, C. D., Buist, M. R., Kenter, G. G., van de Vijver, M. J., & Jordanova, E. S. (2014) · Journal of Immunology Research · doi:10.1155/2014/274584 · Cited by 58
Experimental Production of Polycythemia in Humans by Administration of Cobalt Chloride
Davis, J. E., & Fields, J. P. (1958) · Experimental Biology and Medicine · doi:10.3181/00379727-99-24395 · Cited by 58
Alexander, E. T., Minton, A. R., Peters, M. C., van Ryn, J., & Gilmour, S. K. (2016) · Oncotarget · doi:10.18632/oncotarget.13300 · Cited by 58
Li, Y., Shen, M., Xu, L. J., Yang, X., Tsai, Y., Keng, P. C., Chen, Y., & Lee, S. O. (2017) · Scientific Reports · doi:10.1038/s41598-017-08483-z · Cited by 58
Seliger, B., Harders, C., Wollscheid, U., Staege, M. S., Reske-Kunz, A. B., & Huber, C. (1996) · PubMed · Cited by 57
Gold - Old Drug with New Potentials
Faa, G., Gerosa, C., Fanni, D., Lachowicz, J. I., & Nurchi, V. M. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170330091438 · Cited by 57
Zohora, F. T., Bidad, K., Pourpak, Z., & Moin, M. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1460685 · Cited by 57
Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy
Akhtar, M. J., Alhadlaq, H. A., Kumar, S., Alrokayan, S., & Ahamed, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1570-1 · Cited by 56
A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL , in a B‐cell ALL cell line
Suto, Y., Sato, Y., Smith, S. D., Rowley, J. D., & Bohlander, S. K. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199704)18:4<269::aid-gcc4>3.0.co;2-z · Cited by 56
Correale, P., Vecchio, M. T. D., Placa, M. L., Montagnani, F., Genova, G. D., Savellini, G. G., Terrosi, C., Mannucci, S., Giorgi, G., Francini, G., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31815b69c8 · Cited by 56
Kim, N., Oh, M., Park, H., & Kim, I. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09330fp · Cited by 56
Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
Westbom, C., Thompson, J. K., Leggett, A., MacPherson, M., Beuschel, S., Pass, H., Vacek, P., & Shukla, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145404 · Cited by 56
Awuah, S. G., Riddell, I. A., & Lippard, S. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615327114 · Cited by 56
A Phase I Study of the Metal Ionophore Clioquinol in Patients With Advanced Hematologic Malignancies
Schimmer, A. D., Jitkova, Y., Gronda, M., Wang, Z., Brandwein, J. M., Chen, C. I., Gupta, V. K., Schuh, A. C., Yee, K. W. L., Chen, J., et al. (2012) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2012.05.005 · Cited by 55
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Alagkiozidis, I., Facciabene, A., Tsiatas, M., Carpenito, C., Benencia, F., Adams, S., Jonak, Z., June, C. H., Powell, D. J., & Coukos, G. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-77 · Cited by 55
In vitro and in vivo Activity of New Rhodium (III) Complexes against Leishmania donovani
Rodríguez-Cabezas, M. N., Mesa-Valle, C., Azzouz, S., Moraleda-Lindez, V., Craciunescu, D. G., Gutiérrez-Rios, M., de Frutos, M. I., & Osuna, A. (2001) · Pharmacology · doi:10.1159/000056121 · Cited by 55
Lichtenstein, A. K., & Pende, D. (1986) · PubMed · Cited by 55
Bechara, R., Antonios, D., Azouri, H., & Pallardy, M. J. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.025 · Cited by 55
Lai, Y.-H., Kuo, C., Kuo, M. T., & Chen, H. H. W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051486 · Cited by 55
Wang, J., Li, L., Cang, H., Shi, G., & Yi, J. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.06.006 · Cited by 54
Kasprzak, K. S., Zastawny, T. H., North, S. L., Riggs, C. W., Diwan, B. A., Rice, J. M., & Dizdaroğlu, M. (1994) · Chemical Research in Toxicology · doi:10.1021/tx00039a009 · Cited by 54
Zetterström, C. K., Jiang, W., Wähämaa, H., Östberg, T., Aveberger, A.-C., Schierbeck, H., Lotze, M. T., Andersson, U., Pisetsky, D. S., & Erlandsson Harris, H. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507323 · Cited by 54
Flamme, M., Cressey, P., Lü, C., Bruno, P. M., Eskandari, A., Hemann, M. T., Hogarth, G., & Suntharalingam, K. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701837 · Cited by 54
Pircher, A., Gamerith, G., Amann, A., Reinold, S., Popper, H., Gächter, A., Pall, G., Wöll, E., Jamnig, H., Gastl, G. A., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.04.001 · Cited by 53
Chattopadhyay, S., Dash, S. K., Ghosh, T., Das, D., Pramanik, P., & Roy, S. (2013) · Cancer Nanotechnology · doi:10.1007/s12645-013-0042-7 · Cited by 53
Speciation in Metal Toxicity and Metal-Based Therapeutics
Templeton, D. M. (2015) · Toxics · doi:10.3390/toxics3020170 · Cited by 52
Chemo-Immunotherapy with Oxaliplatin and Interleukin-7 Inhibits Colon Cancer Metastasis in Mice
Gou, H., Huang, J., Shi, H., Chen, X.-C., & Wang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085789 · Cited by 52
Pattern response of dendritic cells in the tumor microenvironment and breast cancer
da Cunha, A., Michelin, M. A., & Murta, E. F. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.495 · Cited by 51
Tel, J., Hato, S. V., Torensma, R., Buschow, S. I., Figdor, C. G., Lesterhuis, W. J., & de Vries, I. J. M. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1189-x · Cited by 51
NKG2D: A versatile player in the immune system
Jelenčić, V., Lenartić, M., Wensveen, F. M., & Polić, B. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.04.006 · Cited by 51
Matsuzaki, I., Suzuki, H., Kitamura, M., Minamiya, Y., Kawai, H., & Ogawa, J. (2000) · Oncology · doi:10.1159/000012192 · Cited by 51
Markowska, A., Kasprzak, B., Jaszczyńska-Nowinka, K., Lubin, J., & Markowska, J. (2015) · Współczesna Onkologia · doi:10.5114/wo.2015.54386 · Cited by 51
Licona, C., Spaety, M.-É., Capuozzo, A., Ali, M., Santamaria, R., Armant, O., Delalande, F., DORSSELAER, A. V., Cianférani, S., Spencer, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13711 · Cited by 51
Chen, J., Huang, X., Huang, G., Chen, Y., Chen, L., & Song, H. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.1116 · Cited by 50
Hutterer, G. C., Sobolev, N., Ehrlich, G., Gutschi, T., Stojaković, T., Mannweiler, S., Pummer, K., Zigeuner, R. E., Pichler, M., & Dalpiaz, O. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202658 · Cited by 50
Sun, Z., Mohamed, M. A. A., Park, S. Y., & Yi, T. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.09.016 · Cited by 50
Fennell, D. A., Kirkpatrick, E., Cozens, K., Nye, M., Lester, J., Hanna, G., Steele, N., Szlosarek, P., Danson, S., Lord, J., et al. (2018) · Trials · doi:10.1186/s13063-018-2602-y · Cited by 50
Önal, C., Güler, O. C., & Yıldırım, B. A. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000741 · Cited by 50
M1 macrophage triggered by Mincle leads to a deterioration of acute kidney injury
Inoue, T. (2017) · Kidney International · doi:10.1016/j.kint.2016.11.026 · Cited by 50
Marelli, G., Erreni, M., Anselmo, A., Taverniti, V., Guglielmetti, S., Mantovani, A., & Allavena, P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2501 · Cited by 50
Meazza, C., Cefalo, G., Massimino, M., Daolio, P. A., Pastorino, U., Scanagatta, P., Morosi, C., Podda, M. G., Ferrari, A., Terenziani, M., et al. (2017) · Medical Oncology · doi:10.1007/s12032-017-1052-9 · Cited by 50
Bellone (2009) · International Journal of Oncology · doi:10.3892/ijo_00000301 · Cited by 49
Clinical and pharmacokinetic evaluation of satraplatin
Doshi, G. K., Sonpavde, G., & Sternberg, C. N. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.636352 · Cited by 49
Bordignon, V., Palamara, F., Cordiali‐Fei, P., Vento, A., Aiello, A., Picardo, M., Ensoli, F., & Cristaudo, A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-19 · Cited by 49
TUMOR-ASSOCIATED ANTIGENS: FROM DISCOVERY TO IMMUNITY
Lewis, J. D., Reilly, B. D., & Bright, R. K. (2003) · International Reviews of Immunology · doi:10.1080/08830180305221 · Cited by 49
Kim, C., Lee, J. H., Kim, W., Li, D., Kim, Y., Lee, K., & Kim, S. K. (2016) · Molecules · doi:10.3390/molecules21091253 · Cited by 49
Emile, J., Julié, C., Malicot, K. L., Lepage, C., Tabernero, J. M., Mini, E., Folprecht, G., Laethem, J. V., Dimet, S., Boulagnon‐Rombi, C., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.04.025 · Cited by 49
Cavalieri, S., Rivoltini, L., Bergamini, C., Locati, L. D., Licitra, L. F., & Bossi, P. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.03.003 · Cited by 49
Jeong, H., Kim, S., Moon, P., Kim, N., Kim, J., Park, R., Kim, M., Park, B. R., Jeong, S., Um, J., et al. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21168 · Cited by 48
Inherited disorders of cobalamin metabolism
Qureshi, A. A., Rosenblatt, D. S., & Cooper, B. A. (1994) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)90022-1 · Cited by 48
Immunotherapy: Beyond Anti–PD-1 and Anti–PD-L1 Therapies
Antonia, S. J., Vansteenkiste, J. F., & Moon, E. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_158712 · Cited by 48
Differentiation syndrome in patients with acute promyelocytic leukemia
Rogers, J. E., & Yang, D. (2011) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155211399163 · Cited by 48
Secondary myelodysplastic syndromes and leukemias.
Fj, G., & Hp, K. (1994) · PubMed · Cited by 47
Therapy-related Leukemia and Myelodysplasia: Evolving Concepts of Pathogenesis and Treatment
Rund, D. G., & Ben‐Yehuda, D. (2004) · Hematology · doi:10.1080/10245330410001701503 · Cited by 47
Sharma, R., Sharma, P. R., Kim, Y., Leitinger, N., Lee, J. K., Fu, S. M., & Ju, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002677 · Cited by 47
Burchiel, S. W., Mitchell, L., Lauer, F. T., Sun, X. H., McDonald, J. D., Hudson, L. G., & Liu, K. J. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.09.019 · Cited by 47
Is copper chelation an effective anti-angiogenic strategy for cancer treatment?
Antoniades, V., Sioga, A., Dietrich, E. M., Meditskou, S., Ekonomou, L., & Antoniades, K. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.035 · Cited by 47
Simon, A., Kourié, H. R., & Kerger, J. N. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0179-6 · Cited by 47
Sun, J. C., & Lanier, L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029538 · Cited by 47
Second Neoplasms in Pediatric Patients Treated for Cancer: A Center??s 30-year Experience
lar, K. A., Varan, A., Aky�z, C., Selek, U., Kutluk, M. T., n, B. Y., Atahan, L., & u, M. N. B. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200606000-00010 · Cited by 46
Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide
Shackelford, D. B., Kenific, C. M., Blusztajn, A., Waxman, S., & Ren, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1774 · Cited by 46
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
Bernsen, M. R., Håkansson, L., Gustafsson, B., Krysander, L., Rettrup, B., Ruiter, D., & Håkansson, A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600703 · Cited by 46
van Vliet, A. R., Martin, S., Garg, A. D., & Agostinis, P. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.010 · Cited by 46
Márkász, L., Skribek, H., Uhlin, M., Ötvös, R. H.-G., Flaberg, E., Eksborg, S., Oláh, É., Stuber, G., & Székely, L. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181628b76 · Cited by 45
Disruption of Mitotic Progression by Arsenic
States, J. C. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0306-7 · Cited by 45
Siew, Y.-Y., Neo, S.-Y., Yew, H.-C., Lim, S.-W., Ng, Y.-C., Lew, S.-M., Seetoh, W.-G., Seow, S.-V., & Koh, H. (2015) · International Immunology · doi:10.1093/intimm/dxv041 · Cited by 45
Tamura, K., Hazama, S., Yamaguchi, R., Imoto, S., Takenouchi, H., Inoue, Y., Kanekiyo, S., Shindo, Y., Miyano, S., Nakamura, Y., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.4465 · Cited by 45
Wu, K., Tan, M., Jiang, J., Mu, X., Wang, J.-R., Zhou, W., Wang, X., Li, M., He, Y., & Liu, Z. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.01.012 · Cited by 45
Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy
Zhang, S., Wu, M. Y., & Wang, F. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2018.170 · Cited by 45
Madeira, J. M., Bajwa, E., Stuart, M., Hashioka, S., & Klegeris, A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.615 · Cited by 44
Aguiar, P. N., De Mello, R. A., Barreto, C. L. M. N., Perry, L. A., Penny-Dimri, J., Tadokoro, H., & Lopes, G. L. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000200 · Cited by 44
Oncostatin M: Potential Implications for Malignancy and Metabolism
Stephens, J. M., & Elks, C. M. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170704122559 · Cited by 44
Occupational allergic contact dermatitis caused by rhodium solutions
Goossens, A. E., Cattaert, N., Nemery, B., Boey, L., & Graef, E. D. (2011) · Contact Dermatitis · doi:10.1111/j.1600-0536.2010.01808.x · Cited by 43
Montagner, D., Gandin, V., Marzano, C., & Erxleben, A. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.01.013 · Cited by 43
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
Coosemans, A., Decoene, J., Baert, T., Laenen, A., Kasran, A., Verschuere, T., Seys, S., & Vergote, I. B. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1111505 · Cited by 43
Joimel, U., Gest, C., Soria, J., Pritchard, L.-L., Alexandre, J., Laurent, M., Blot, E., Cazin, L., Vannier, J.-P., Varin, R., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-375 · Cited by 43
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
Argyriou, A. A. (2015) · Toxics · doi:10.3390/toxics3020187 · Cited by 42
Hu, A.-P., Du, J., Li, J.-Y., & Liu, J.-W. (2008) · Inflammation Research · doi:10.1007/s00011-007-7193-0 · Cited by 42
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes
Pascoli, M. D., Rodella, L. F., Sacerdoti, D., Bolognesi, M., Türkseven, S., & Abraham, N. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.082 · Cited by 42
Gameiro, S. R., Caballero, J. A., & Hodge, J. W. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1203 · Cited by 42
Zhao, M., LI, H., Li, L., & Zhang, Y. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1574 · Cited by 42
Chattopadhyay, S., Dash, S. K., Ghosh, T., Das, S., Tripathy, S., Mandal, D., Das, D., Pramanik, P., & Roy, S. (2013) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1044-y · Cited by 42
Moserova, I., Truxova, I., Garg, A. D., Tomala, J., Agostinis, P., Cartron, P. F., Vosahlikova, S., Kovar, M., Spisek, R., & Fucikova, J. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1258505 · Cited by 42
Bräunlein, E., & Krackhardt, A. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01702 · Cited by 42
Kaatsch, P., Reinisch, I., Spix, C., Berthold, F., Janka-Schaub, G. E., Mergenthaler, A., Michaelis, J., & Blettner, M. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9315-1 · Cited by 42
Starkweather, A. R. (2010) · Nursing Research and Practice · doi:10.1155/2010/281531 · Cited by 42
Blanářová, O. V., Jelínková, I., Szöőr, Á., Skender, B., Souček, K., Horváth, V., Vaculová, A. H., Anděra, L., Sova, P., Szöllõsi, J., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq220 · Cited by 42
Li, X., Shenashen, M. A., Wang, X., Ito, A., Taniguchi, A., & El‐Safty, S. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12446-9 · Cited by 42
Kossman, S. E., & Weiss, M. A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<620::aid-cncr19>3.0.co;2-# · Cited by 42
Chauhan, P., Sodhi, A., & Shrivastava, A. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.012 · Cited by 41
Chakraborty, P., Chatterjee, S., Ganguly, A., Saha, P., Adhikary, A., Das, T., Chatterjee, M., & Choudhuri, S. K. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0611287 · Cited by 41
Papaioannou, M., Mylonas, I., Kast, R. E., & Bruning, A. (2013) · Oncoscience · doi:10.18632/oncoscience.5 · Cited by 41
Metal based nanoparticles as cancer antigen delivery vehicles for macrophage based antitumor vaccine
Chattopadhyay, S., Dash, S. K., Mandal, D., Das, B., Tripathy, S., Dey, A., Pramanik, P., & Roy, S. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.12.053 · Cited by 41
Lightening up Ruthenium Complexes to Fight Cancer?
Mari, C., & Gasser, G. (2015) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2015.176 · Cited by 41
Jung, Y.-J., Lee, J. H., Kim, W., Yoon, S. H., & Kim, S. K. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1556-z · Cited by 41
Long term platinum-induced ototoxicity in pediatric patients
Sofia Waissbluth, A., Chuang, A., Valle, Á. D., & Cordova, M. (2018) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2018.01.028 · Cited by 41
Kaluđerović, G. N., Krajnović, T., Momčilović, M. B., Stošić‐Grujičić, S., Mijatović, S., Maksimović‐Ivanić, D., & Hey‐Hawkins, E. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.09.006 · Cited by 40
Dertinger, S. D., Avlasevich, S. L., Torous, D. K., Bemis, J. C., Phonethepswath, S., Labash, C., Carlson, K., Mereness, J. A., Cottom, J., Palis, J., et al. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu078 · Cited by 40
Cascales, M., Martín‐Sanz, P., Craciunescu, D. G., Mayo, I., Aguilar, A., Robles-Chillida, E. M., & Cascales, C. (1991) · Carcinogenesis · doi:10.1093/carcin/12.2.233 · Cited by 40
Doi, Y., Okada, T., Matsumoto, H., Ichihara, M., Ishida, T., & Kiwada, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01678.x · Cited by 40
Du, L., Herbst, R. S., & Morgensztern, D. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.08.004 · Cited by 40
Zhu, H., Fang, X., Zhang, D., Wu, W., Shao, M., Wang, L., & Gu, J. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1187-0 · Cited by 40
Webb, J. A., Ou, Y., Faley, S. L., Paul, E. P., Hittinger, J. P., Cutright, C. C., Lin, E. C., Bellan, L. M., & Bardhan, R. (2017) · ACS Omega · doi:10.1021/acsomega.7b00527 · Cited by 40
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
O’Donnell, T. J., Christie, E. L., Ahuja, A., Buros, J. L., Aksoy, B. A., Bowtell, D. D. L., Snyder, A., & Hammerbacher, J. (2018) · BMC Cancer · doi:10.1186/s12885-017-3825-0 · Cited by 40
Occupational immediate‐type asthma and rhinitis due to rhodium salts
Merget, R., Sander, I., van Kampen, V., Raulf, M., Ulmer, H., Kulzer, R., & Bruening, T. (2009) · American Journal of Industrial Medicine · doi:10.1002/ajim.20786 · Cited by 39
Sommariva, M., Cecco, L. D., Cesare, M. D., Sfondrini, L., Ménard, S., Melani, C. C., Delia, D., Zaffaroni, N., Pratesi, G., Uva, V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1285 · Cited by 39
Li, D., Kim, W., Shin, D., Jung, Y.-J., Bae, H., & Kim, S. K. (2016) · Toxins · doi:10.3390/toxins8010027 · Cited by 39
Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
Magnarin, M., Bergamo, A., Carotenuto, M. E., Zorzet, S., & Sava, G. (2000) · PubMed · Cited by 39
Mechanistic Insights into Gold Organometallic Compounds and their Biomedical Applications
Jürgens, S., & Casini, A. (2017) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2017.92 · Cited by 39
Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
Marković, B. S., Gazdic, M., Arsenijević, A., Jovicic, N. U., Jeremic, J. N., Djonov, V., Arsenijević, N., Lukić, M. L., & Volarević, V. (2017) · Stem Cells International · doi:10.1155/2017/1315378 · Cited by 39
Cardo, L. F., & Hannon, M. J. (2018) · De Gruyter eBooks · doi:10.1515/9783110470734-011 · Cited by 39
Rothschild, U., Müller, L., Lechner, A., Schlößer, H., Beutner, D., Laubli, H. P., Zippelius, A., & Rothschild, S. I. (2018) · Swiss Medical Weekly · doi:10.4414/smw.2018.14625 · Cited by 39
Agrawal, S., Singh, N. K., Aggarwal, R. C., Sodhi, A., & Tandon, P. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00152a006 · Cited by 38
Ibatici, A., Pica, G. M., Nati, S., Vitolo, U., Botto, B., Ciochetto, C., Petrini, M., Galimberti, S., Ciabatti, E., Orciuolo, E., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12695 · Cited by 38
Binding Interaction of HMGB4 with Cisplatin-Modified DNA
Park, S., & Lippard, S. J. (2012) · Biochemistry · doi:10.1021/bi300649v · Cited by 38
Arsenite medicinal use, metabolism, pharmacokinetics and monitoring in human hair
Nicolis, I., Curis, E., Deschamps, P., & Bénazeth, S. (2009) · Biochimie · doi:10.1016/j.biochi.2009.06.003 · Cited by 38
Research works printed but not linked: 47
- van der Most R. G., 2005, Discovery Medicine, 5, 265
- Alberts B., 2015, Mol. Biol. Cell
- Seliger B., 1996, Exp. Hematol., 24, 1275
- Fink D., 1996, Cancer Res., 56, 4881
- Yoshikawa A., 1997, Kobe J. Med. Sci., 43, 109
- 10.1007/s00775-018- 1546-8 · doi:10.1007/s00775-018-
- Rosenberg, B. In Advances in Antimicrobial and Antineoplastic Chemotherapy, University Park Press: Baltimore, 1972; Vol. 11.
- 10.1002/(SICI)1098-2264(199704)18:4<286::AID-GCC6>3.0.CO;2-X · doi:10.1002/(sici)1098-2264(199704)18:4<286::aid-gcc6>3.0.co;2-x
- Dempsey J. L., 1985, Cancer Res., 45, 2873
- Nio Y., 2000, Anticancer Res., 20, 3293
- Qin X., 2010, Cell. Mol. Biol. (Noisy- le-grand), 56, 1366
- Kleinerman E. S., 1980, Cancer Res., 40, 3099
- Lichtenstein A. K., 1986, Cancer Res., 46, 639
- 10.1002/1097-0142(19930215)71:4<1313::AID-CNCR2820710424>3.0.CO;2-# · doi:10.1002/1097-0142(19930215)71:4<1313::aid-cncr2820710424>3.0.co;2-#
- Yamaue H., 1991, J. Clin. Lab. Immunol., 35, 165
- 10.1002/(SICI)1097-0215(19971104)73:3<416::AID-IJC17>3.0.CO;2-A · doi:10.1002/(sici)1097-0215(19971104)73:3<416::aid-ijc17>3.0.co;2-a
- Jiang J., 2006, Anticancer Res., 26, 2237
- Ujiie T., 1989, Jpn. J. Exp. Med., 59, 17
- Maeda K., 2011, Anticancer Res., 31, 4569
- Miller W. H., 2002, Cancer Res., 62, 3893
- 10.1097/CJI.0b013e3181755deb · DOI
- Kreuser E. D., 1992, Semin. Oncol., 19, 73
- Magnarin M., 2000, Anticancer Res., 20, 2939
- Nardon C., 2014, Anticancer Res., 34, 487
- Hashimoto K., 1994, J. Rheumatol., 21, 1020
- Yan A., 1990, J. Rheumatol., 17, 47
- Wang X. D., 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 17, 533
- 10.1371/journal.pone.0100933 · DOI · Paper page
- Korbecki J., 2012, Acta Biochim. Polym., 59, 195
- 10.3109/1547691X.2014.996681 · DOI
- Desoize B., 2004, Anticancer Res., 24, 1529
- Sava G., 1985, Anticancer Res., 5, 249
- Boscolo P., 2004, Ann. Clin. Lab. Sci., 34, 299
- Brewer G. J., 2000, Clin. Cancer Res., 6, 1
- Redman B. G., 2003, Clin. Cancer Res., 9, 1666
- Pan Q., 2003, Mol. Cancer Res., 1, 701
- Lukasewycz O. A., 1982, J. Natl. Cancer Inst., 69, 489
- 10.1515/9783110470734-016 · doi:10.1515/9783110470734-016
- Eriksson M., 2009, Anticancer Res., 29, 11
- Signat B., 2011, Curr. Issues Mol. Biol., 13, 25
- Sonis S. T., 2004, J. Support. Oncol., 2, 21
- 10.1053/sonc.2002.35524 · doi:10.1053/sonc.2002.35524 · Paper page
- Juhn S. K., 2001, Int. Tinnitus J., 7, 72
- Boussios S., 2012, Ann. Gastroenterol., 25, 106
- Takeyama K., 2000, Int. J. Hematol., 71, 144
- Giles F. J., 1994, Curr. Opin. Hematol., 1, 256
- Lu J., 2017, Ochsner J., 17, 379
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Toxicity of gold nanoparticles (AuNPs): A review
Sani, A., Cao, C., & Cui, D. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100991 · Cited by 454
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
New Designs for Phototherapeutic Transition Metal Complexes
Imberti, C., Zhang, P., Huang, H., & Sadler, P. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201905171 · Cited by 443
The immune microenvironment in cartilage injury and repair
Li, M., Yin, H., Yan, Z., Li, H., Wu, J., Wang, Y., Wei, F., Tian, G., Ning, C., Li, H., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.12.006 · Cited by 403
Metadata
- Authors
- Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W.
- Affiliations
- Comprehensive Cancer Center Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Berger, Walter
- ORCID
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-29
- Volume
- 119
- Issue
- 2
- Pages
- 1519-1624
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2903051221
- Cited by
- 355
- References
- 1,298
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 47 · 2023: 51 · 2022: 49 · 2021: 45 · 2020: 53 · 2019: 38
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- Funders
- FP7 People: Marie-Curie Actions (609431)
- Universit?t Wien
- Medizinische Universit?t Wien
- Johanna Mahlke, geb. Obermann-Stiftung zur F?rderung der Krebsforschung an der Universit?t Wien
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- metal-based anticancer agents, antitumor immunity, immune surveillance, immune evasion, cancer immunotherapy, immune checkpoint inhibitors, tumor microenvironment, innate and adaptive immunity
- MeSH terms
- Gastrointestinal Microbiome, Antineoplastic Agents, Humans, Immunity, Innate, Immunotherapy, Lymphocytes, Metals, Neoplasms, Nanoparticles, Coordination Complexes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.